Prior to joining eStruxture, Strahan was the Senior Vice President of Product & Strategy at Q9, a pan-Canadian data center provider that was recently fully acquired by Bell Canada. Before Q9, Strahan was the Vice President of Marketing & Product Development for Scalar Decisions. Strahan has also held senior leadership positions in the Hosting & Cloud Computing practice of Bell Canada, as well as management consulting and hands-on IT services delivery roles.
A respected cloud & IT infrastructure expert, Strahan has written several articles on Cloud Computing and spoken frequently at vendor and analyst conferences, including CICA Audit Conference, ITAC in Ottawa, DCIE in Montreal, L’Expert in Toronto, IDC Conference, ISAAC, and IT Canada. Strahan is also a former member of the Board of Directors for the Toronto Public Library, North America’s largest Public Library system.
Hyejung Yang is the Team Leader of the Clinical New Drug Team at Daewoong Pharmaceutical. She has over 14 years of experience in global clinical development, leading Phase I–III trials across multiple therapeutic areas, with a particular focus on new drug development projects. She has extensive expertise in project leadership, study start-up, investigational product management, and global site/vendor communication. As a clinical team leader, she has directed cross-functional teams and contributed to IND submissions, ensuring successful execution of global clinical trials.
– 23Y Clinical Trial & New Drug Development Expert Professional
– Global & Local Trials Experiences including the 1st Phase 2 COVID-19 New Oral-drug Trial PM in Korea & USA
– Global CROs and Local Pharmacies Experiences
– All-round Experts in Clinical Trials (Medicines & Devices)
Dr. Sang Ho Ma, Ph.D. in Pharmacy, is Vice President of Development at A&J Science and a member of the Expert Committee of the Ministry of Food and Drug Safety (MFDS). With over 20 years of
experience in drug discovery and development, including CMC, regulatory affairs, and clinical research, he provides expertise across immuno-oncology, rare diseases, infectious diseases, and vaccines.
Jaeyoung Hyun serves as Head of the Business Development Unit at GCCL(Global Clinical Central Lab), a leading central lab in Asia Pacific specializing in clinical trial sample analysis for global pharmaceutical and biotech sponsors. In this role, he oversees domestic and global client engagement, strategic sales, and partnership development, driving GCCL’s growth and international presence.
With a long-standing career in domestic sales and business development within the pharmaceutical and healthcare industries, Mr. Hyun has cultivated deep expertise in fostering client relationships, shaping commercial strategies, and supporting multinational clinical programs. His professional background includes extensive collaboration with pharma and biotech companies, with a focus on overcoming logistical barriers in clinical sample management—an area he will address in his OCT Korea 2025 session, “Optimizing Central Lab Supply Chains: Overcoming Logistical Barriers in Clinical Sample Management.”
Amy is a seasoned imaging clinical trial expert with a PhD in Biomedical Sciences and extensive experience in the design, execution, and evaluation of imaging across multiple therapeutic areas, including oncology, ophthalmology, neurology, dermatology, musculoskeletal, and gastroenterology. With nearly a decade of leadership in managing imaging projects, she has worked with global pharmaceutical companies, leading CROs, and major hospitals worldwide. Her career journey spans roles from imaging project manager to CEO of a Singapore-based imaging CRO, and she now brings her expertise to a global imaging CRO.
